AstraZeneca to resume vaccine trials after ‘potentially unexplained illness’ prompted pause

AstraZeneca announced that it was restarting phase three coronavirus vaccine trials after they were paused when a participant became ill.

The pharmaceutical giant announced the resumption on Saturday after the trials were put on hold on Sunday. The patient in question, a woman, was from the United Kingdom and reportedly suffered a rare spinal cord injury.

AstraZeneca did not disclose further information about the illness in its Saturday statement but said that it was “committed to the safety…

Read Full Article


Please enter your comment!
Please enter your name here